Free Trial
NYSE:SOLV

Solventum (SOLV) Stock Price, News & Analysis

$56.41
+1.36 (+2.47%)
(As of 06/7/2024 ET)
Today's Range
$54.47
$56.78
50-Day Range
$55.05
$70.04
52-Week Range
$54.47
$96.05
Volume
1.53 million shs
Average Volume
1.91 million shs
Market Capitalization
$9.74 billion
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
$65.75

About Solventum

Solventum Corporation, a healthcare company, engages in the developing, manufacturing, and commercializing a portfolio of solutions to address critical customer and patient needs. It operates through four segments: Medsurg, Dental Solutions, Health Information Systems, and Purification and Filtration. The Medsurg segment is a provider of solutions including advanced wound care, I.V. site management, sterilization assurance, temperature management, surgical supplies, stethoscopes, and medical electrodes. The Dental Solutions segment provides a comprehensive suite of dental and orthodontic products including brackets, aligners, restorative cements, and bonding agents. The Health Information Systems provides software solutions including computer-assisted, physician documentation, direct-to-bill and coding automation, classification methodologies, speech, recognition, and data visualization platforms. The Purification and Filtration segment provides purification and filtration technologies including filters, purifiers, cartridges, and membranes. The company was incorporated in 2023 and is based in Saint Paul, Minnesota.

SOLV Stock Price History

SOLV Stock News Headlines

3 Affordable Stocks That Won’t Stay Down Much Longer (SOLV)
Three stocks have fallen into value investor radars, as they provide double-digit discounts to their peers and still generate above-average returns on capital
TRC Amends Its Tender Offer for Solventum Corporation
Unit Corporation Reports First Quarter Results
Albemarle (NYSE: ALB)
Solvac SA SOLV
See More Headlines
Receive SOLV Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Solventum and its competitors with MarketBeat's FREE daily newsletter.

Company Calendar

Last Earnings
5/09/2024
Today
6/09/2024
Next Earnings (Estimated)
8/08/2024
Fiscal Year End
12/31/2024

Industry, Sector and Symbol

Sector
Medical
Industry
Surgical & medical instruments
Sub-Industry
N/A
Fax
N/A
Employees
N/A
Year Founded
N/A

Price Target and Rating

Average Stock Price Target
$65.75
High Stock Price Target
$70.00
Low Stock Price Target
$54.00
Potential Upside/Downside
+16.6%
Consensus Rating
Reduce
Rating Score (0-4)
1.80
Research Coverage
5 Analysts

Profitability

Pretax Margin
N/A

Debt

Sales & Book Value

Annual Sales
N/A

Miscellaneous

Free Float
N/A
Market Cap
$9.74 billion
Optionable
Optionable
Beta
N/A
5G Stocks: The Path Forward is Profitable Cover

Click the link below and we'll send you MarketBeat's guide to investing in 5G and which 5G stocks show the most promise.

Get This Free Report

SOLV Stock Analysis - Frequently Asked Questions

Should I buy or sell Solventum stock right now?

5 Wall Street analysts have issued "buy," "hold," and "sell" ratings for Solventum in the last twelve months. There are currently 1 sell rating and 4 hold ratings for the stock. The consensus among Wall Street analysts is that investors should "reduce" SOLV shares.
View SOLV analyst ratings
or view top-rated stocks.

What is Solventum's stock price target for 2024?

5 brokerages have issued 12 month target prices for Solventum's shares. Their SOLV share price targets range from $54.00 to $70.00. On average, they anticipate the company's stock price to reach $65.75 in the next year. This suggests a possible upside of 16.6% from the stock's current price.
View analysts price targets for SOLV
or view top-rated stocks among Wall Street analysts.

How have SOLV shares performed in 2024?

Solventum's stock was trading at $66.90 at the beginning of 2024. Since then, SOLV shares have decreased by 15.7% and is now trading at $56.41.
View the best growth stocks for 2024 here
.

When is Solventum's next earnings date?

The company is scheduled to release its next quarterly earnings announcement on Thursday, August 8th 2024.
View our SOLV earnings forecast
.

How were Solventum's earnings last quarter?

Solventum Co. (NYSE:SOLV) issued its earnings results on Thursday, May, 9th. The company reported $2.08 EPS for the quarter, topping analysts' consensus estimates of $1.67 by $0.41. The firm earned $2.02 billion during the quarter, compared to analysts' expectations of $1.99 billion.

What guidance has Solventum issued on next quarter's earnings?

Solventum issued an update on its FY 2024 earnings guidance on Thursday, May, 9th. The company provided earnings per share (EPS) guidance of 6.100-6.400 for the period, compared to the consensus estimate of 6.270. The company issued revenue guidance of -.

Who are Solventum's major shareholders?

Solventum's stock is owned by a number of institutional and retail investors. Top institutional investors include Walleye Trading LLC (0.00%), Price T Rowe Associates Inc. MD (0.05%), Mitsubishi UFJ Trust & Banking Corp (0.05%), Magnetar Financial LLC (0.03%), Alpine Global Management LLC (0.01%) and Fifth Lane Capital LP (0.01%).

How do I buy shares of Solventum?

Shares of SOLV stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.
Compare Top Brokerages Here.

This page (NYSE:SOLV) was last updated on 6/9/2024 by MarketBeat.com Staff

From Our Partners